CLASS II ONGOING Device recall · Reported 12 Jun 2024 · FDA Enforcement Report

Leica HistoCore Pegasus Tissue Processor recalled

Leica Biosystems Nussloch is recalling Leica HistoCore Pegasus Tissue Processor, distributed nationwide in the US. The recall was initiated on 10 Apr 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll devices with serial numbers: G0061 - G0154, G0156 - G0530, G0532 - G0779, G0781, G0782; UDI-DI 04049188216397.
Quantity recalled141 devices

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1947-2024
FDA event ID
94470
Recalling firm
Leica Biosystems Nussloch, Nussloch, N/A
Classification
Class II
Status
Ongoing
Recall initiated
10 Apr 2024
FDA classified
4 Jun 2024
Reported
12 Jun 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

10 Apr 2024Recall initiated by company
4 Jun 2024Classified by FDA+55 days
12 Jun 2024Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Poorly processed and/or damaged biopsy tissue specimens on the device resulting from reagent levels exceeding the maximum fill level marks on reagent bottles or in the paraffin tanks.

Product as listed by the FDA

Leica HistoCore PEGASUS Tissue Processor, REF 14048858005.

Where it was distributed

Worldwide - US Nationwide distribution including in the states of AK, AL, AZ, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MT, NC, NJ, NV, NY, OH, TN, TX, UT, VA, WA, and WI. There was also government distribution but no military distribution. The country of Canada.

Nationwide AlaskaAlabamaArizonaCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMichiganMinnesota

Questions about this recall

Why was it recalled?

Poorly processed and/or damaged biopsy tissue specimens on the device resulting from reagent levels exceeding the maximum fill level marks on reagent bottles or in the paraffin tanks.

Which lots are affected?

All devices with serial numbers: G0061 - G0154, G0156 - G0530, G0532 - G0779, G0781, G0782; UDI-DI 04049188216397.

Where was it sold?

Worldwide - US Nationwide distribution including in the states of AK, AL, AZ, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MT, NC, NJ, NV, NY, OH, TN, TX, UT, VA, WA, and WI. There was also government distribution but no military distribution. The country of Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Leica Biosystems Nussloch

All 10
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IILeica Biosystems Cryostats CM1950 recalledLeica Biosystems NusslochDevice MalfunctionNationwide
DeviceCLASS IILeica Biosystems Cryostat recalledLeica Biosystems NusslochOtherNationwide
DeviceCLASS IILeica Biosystems Cryostat recalledLeica Biosystems NusslochOtherNationwide
DeviceCLASS IILeica Biosystems Cryostat recalledLeica Biosystems NusslochOtherNationwide
DeviceCLASS IILeica Biosystems Cryostat recalledLeica Biosystems NusslochOtherNationwide

Other Other Medical Devices recalls

All 13,908